A coalition of 14 Republican state attorneys general sent a formal petition last Friday to the Environmental Protection Agency, asking the agency to designate mifepristone — the primary drug in medication abortion — as a water contaminant. Idaho Attorney General Raúl Labrador is among the signatories, joining counterparts from Alabama, Alaska, Arkansas, Florida, Indiana, Kansas, Kentucky, Louisiana, Missouri, Nebraska, Oklahoma, South Carolina, and Texas.
A parallel letter organized by New Jersey Rep. Chris Smith, carrying the signatures of 18 additional Republican members of Congress, delivered a matching request to EPA Administrator Lee Zeldin on the same day.
The Petition’s Core Argument
The attorneys general describe mifepristone as “a growing threat to the country’s waterways,” arguing that the drug warrants formal regulatory attention under federal environmental law. Their petition asks the EPA to evaluate the medication as a potential contaminant in the nation’s water supply.
Mifepristone functions as one half of a two-drug regimen used to end a pregnancy. The FDA has acknowledged since at least 1996 that the drug can reach the environment through human excretion or improper pharmaceutical disposal, though the agency stated at that time that harmful environmental effects were “not anticipated.”
Nationally, medication abortion made up close to two-thirds of all clinician-provided abortions in states where the procedure remained legal in 2023, making it the dominant method in those jurisdictions.
What Scientists and Environmental Advocates Say
Existing research characterizes medication abortion as safe and effective, and environmental health specialists say no documented evidence currently links mifepristone in wastewater to harm for either aquatic ecosystems or people who consume treated water.
The Center for Biological Diversity stated plainly: “There’s no evidence that medication abortion is affecting U.S. water systems, including drinking water and aquatic wildlife.”
The group’s position reflects a broader scientific consensus that no confirmed environmental risk from the drug has been established, a point critics of the petition say undercuts its regulatory foundation.
State Legislatures and Prior Congressional Action
The multistate petition follows a wave of related activity at the state level. During the 2025 legislative session, seven states collectively put forward nine bills focused on mifepristone’s relationship to water quality, with several of those measures calling for mandatory testing in municipal water systems.
Republican members of Congress made a comparable request to the EPA during the previous year, meaning this latest effort represents a more organized, multi-jurisdictional follow-through on that earlier push.
The Legal Landscape
The overall regulatory picture for mifepristone remains unsettled in the courts. The U.S. Supreme Court ruled last month to maintain telehealth access to the drug while the Fifth Circuit Court of Appeals works through Louisiana v. Food and Drug Administration, meaning the drug’s broader availability hinges on that case’s outcome.
The EPA has not indicated whether it plans to act on the attorneys general’s request. Any formal move to classify mifepristone as a contaminant would require the agency to launch a process under the Safe Drinking Water Act or comparable statute — a proceeding that typically spans multiple years and invites legal challenges.
Idaho Context
Idaho already enforces a near-total abortion prohibition, which means mifepristone’s in-state availability is already sharply curtailed through reproductive health law alone. Even so, Attorney General Labrador’s decision to sign the petition places Idaho at the forefront of the effort to use environmental regulation as an additional avenue of scrutiny around the drug.
For Idaho families and water system managers, no regulatory requirement currently exists around mifepristone in water supplies, and no state or federal agency has identified a confirmed public health concern tied to the drug’s presence in waterways. Whether the EPA takes up the petition will determine if that picture changes.